The Safety Profile of Hepatectomy Following Preoperative Systemic Therapy with Lenvatinib Plus Anti-PD-1 Antibodies Versus Hepatectomy Alone in Patients With Hepatocellular Carcinoma

The Safety Profile of Hepatectomy Following Preoperative Systemic Therapy with Lenvatinib Plus Anti-PD-1 Antibodies Versus Hepatectomy Alone in Patients With Hepatocellular Carcinoma

Objective:. To determine the safety of hepatectomy after combined lenvatinib and anti-PD-1 preoperative systemic therapy (PST) in patients with marginally resectable hepatocellular carcinoma (HCC). Background:. PST followed by hepatectomy (PSTH) is an emerging treatment for HCC. However, the impact...

Full description

Bibliographic Details
Main Authors: Ying-Hao Shen, MD, Cheng Huang, MD, Xiao-Dong Zhu, MD, Ming-Hao Xu, BS, Zhao-Shuo Chen, MS, Chang-Jun Tan, MD, Jian Zhou, MD, Jia Fan, MD, Hui-Chuan Sun, MD
Format: Article
Language:English
Published: Wolters Kluwer Health 2022-06-01
Series:Annals of Surgery Open
Online Access:http://journals.lww.com/10.1097/AS9.0000000000000163

Internet

http://journals.lww.com/10.1097/AS9.0000000000000163

Similar Items